| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/2004 | WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078746A2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders |
| 09/16/2004 | WO2004078744A2 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| 09/16/2004 | WO2004078742A1 Thiolactones |
| 09/16/2004 | WO2004078741A1 Adiponectin expression promoter |
| 09/16/2004 | WO2004078734A1 TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES |
| 09/16/2004 | WO2004078733A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | WO2004078717A1 Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| 09/16/2004 | WO2004078716A1 Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| 09/16/2004 | WO2004078714A2 Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazouinoxalines and heterocyclic-substituted imidazopyrazines |
| 09/16/2004 | WO2004078704A1 Pharmaceutical compositions containing sulphonic acid derivatives |
| 09/16/2004 | WO2004078695A1 Method for the purification of crocetin |
| 09/16/2004 | WO2004078682A2 Cyclic compounds and compositions as protein kinase inhibitors |
| 09/16/2004 | WO2004078261A1 Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| 09/16/2004 | WO2004078216A2 Use of a tricyclic antidepressant drug for promoting endocytosis |
| 09/16/2004 | WO2004078213A1 Composition for target substance introduction and method of target substance introduction |
| 09/16/2004 | WO2004078212A1 Medicinal composition for regulating release and process for producing the same |
| 09/16/2004 | WO2004078210A1 Preventive for adhesion following abdominal surgery |
| 09/16/2004 | WO2004078205A1 Targeting a protein prc1 for the treatment of pancreatic cancer |
| 09/16/2004 | WO2004078189A1 Use of rutin and isoharmnetin for treating depressive states and depression and other emotion disorders |
| 09/16/2004 | WO2004078188A1 COMPOSITION CONTAINING β-GLUCAN AND CONSTIPATION-RELIEVING DRUG, IMMUNOPOTENTIATOR AND SKIN MOISTENING AGENT USING THE COMPOSITION |
| 09/16/2004 | WO2004078186A1 Ointment preparation for repairing injured skin |
| 09/16/2004 | WO2004078184A1 Use of adenosine receptor agonists in therapy |
| 09/16/2004 | WO2004078183A1 Compounds for the treatment of pain |
| 09/16/2004 | WO2004078182A1 Medicament or nutriceutical combining a soluble poorly-absorbed saccharide and an antiflatulent from the siloxane group |
| 09/16/2004 | WO2004078181A1 Rna interference based methods and compositions for inhibiting hbv gene expression |
| 09/16/2004 | WO2004078180A2 Naaladase inhibitors for treating opioid tolerance |
| 09/16/2004 | WO2004078179A1 Combination therapy for infectious disease |
| 09/16/2004 | WO2004078178A1 Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use |
| 09/16/2004 | WO2004078177A1 Remedy for drug/substance dependence |
| 09/16/2004 | WO2004078175A2 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases |
| 09/16/2004 | WO2004078174A1 Resonance modulator for diagnosis and therapy |
| 09/16/2004 | WO2004078173A1 Tablet having improved dissolution characteristics |
| 09/16/2004 | WO2004078172A2 Sod mimic multifunctional compounds for treating inflammatory bowel disease |
| 09/16/2004 | WO2004078171A1 Tablet containing water-absorbing amino acid |
| 09/16/2004 | WO2004078170A1 Potassium taurate bicarbonate and ascorbate complexes |
| 09/16/2004 | WO2004078169A1 Use of ep2 selective receptor agonists in medical treatment |
| 09/16/2004 | WO2004078168A1 A composition comprising phytosphingosine or a derivative thereof |
| 09/16/2004 | WO2004078167A1 Use of non-immunosuppressive pipecolic acid derivatives for inducing chondrogenic differentiation |
| 09/16/2004 | WO2004078166A2 Use of omega-3-fatty acids in the treatment of diabetic patients |
| 09/16/2004 | WO2004078163A2 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/16/2004 | WO2004078162A1 Nanoparticulate topiramate formulations |
| 09/16/2004 | WO2004078161A1 Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 09/16/2004 | WO2004078157A2 Regulation of mammalian hair growth |
| 09/16/2004 | WO2004078149A1 Cosmetic and/or pharmaceutical preparations containing micro-encapsulated plant extracts |
| 09/16/2004 | WO2004078145A2 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis |
| 09/16/2004 | WO2004078144A2 Diphenylethylene compounds and uses thereof |
| 09/16/2004 | WO2004078142A2 Compositions and methods for preventing and treating endotoxin-related diseases and conditions |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078139A2 Therapeutic compositions |
| 09/16/2004 | WO2004078138A2 Prophylactic treatment of uv-induced epidermal neoplasia |
| 09/16/2004 | WO2004078136A2 Pyridinium salts, compounds and methods of use |
| 09/16/2004 | WO2004078133A2 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078129A2 Method for decreasing low density lipoprotein |
| 09/16/2004 | WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078127A2 Continuous delivery methods for treating hepatitis virus infection |
| 09/16/2004 | WO2004078126A2 Compositions and methods with enhanced therapeutic activity |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004078122A2 Invisible patch for active agnet controlled delivery |
| 09/16/2004 | WO2004078119A2 Substituted thiophenes with antibacterial activity |
| 09/16/2004 | WO2004078117A2 Method for increasing hair growth |
| 09/16/2004 | WO2004078116A2 P38 inhibitors and methods of use thereof |
| 09/16/2004 | WO2004078114A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| 09/16/2004 | WO2004078113A2 Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents |
| 09/16/2004 | WO2004078111A2 Extended release minocycline compositions and processes for their preparation |
| 09/16/2004 | WO2004078108A2 Fibrate tablet and method for the production thereof |
| 09/16/2004 | WO2004078105A2 Fondaparinux sodium composition of high purity, method for production of said composition and pharmaceutical compositions containing the same as active ingredient |
| 09/16/2004 | WO2004078104A2 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 09/16/2004 | WO2004078102A2 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 09/16/2004 | WO2004078080A1 Device for stimulating the female sexual organ, packaging and dispensing member |
| 09/16/2004 | WO2004077938A2 Novel chemical entities and methods for their use in treatment of metabolic disorders |
| 09/16/2004 | WO2004069228A3 Sustained release formulations of venlafaxine |
| 09/16/2004 | WO2004067027A3 Osteogenic composition |
| 09/16/2004 | WO2004066980A3 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
| 09/16/2004 | WO2004066979A3 Sustained release device and method for ocular delivery of adrenergic agents |
| 09/16/2004 | WO2004062576A3 Methods for treating ocular diseases |
| 09/16/2004 | WO2004062557A3 Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 09/16/2004 | WO2004058176A3 Acyclic pyrazole compounds |
| 09/16/2004 | WO2004058152A3 An extended release pharmaceutical composition of phenytoin sodium |
| 09/16/2004 | WO2004056380A3 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |
| 09/16/2004 | WO2004056322A3 Antibiotics containing borinic acid complexes and methods of use |
| 09/16/2004 | WO2004052295A3 Compositions and methods for nutrition supplementation |
| 09/16/2004 | WO2004052283A3 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 09/16/2004 | WO2004050706A3 Regulatory t-cells |
| 09/16/2004 | WO2004050096A3 Phosphoantigens for regulating an immune response |
| 09/16/2004 | WO2004048544A3 Ca ix-specific inhibitors |
| 09/16/2004 | WO2004047837A3 Beta-blockers having antioxidant and nitric oxide-donor activity |
| 09/16/2004 | WO2004047730A3 Compounds for inhibition of hiv infection by blocking hiv entry |
| 09/16/2004 | WO2004047726A3 Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease |
| 09/16/2004 | WO2004045609A3 Hydroxypyridinones for the local treatment of skin microcirculatory disorders |
| 09/16/2004 | WO2004043389B1 Methods of treating cancer and related methods |
| 09/16/2004 | WO2004043365A3 Method for treatment of premature ejaculation in humans |
| 09/16/2004 | WO2004041272A3 Use of serotonin receptor antagonists for the treatment of sleep apnea |
| 09/16/2004 | WO2004041205A3 Ha4, a new osteoblast- and chondrocyte-specific small secreted peptide, compositions and methods of use |
| 09/16/2004 | WO2004041171A3 Shivering supression during cooling to lower body temperature |
| 09/16/2004 | WO2004041157A3 Group b streptococcus vaccine |
| 09/16/2004 | WO2004039803A3 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 09/16/2004 | WO2004037211A3 Taxane metabolites |
| 09/16/2004 | WO2004037203A3 Sustained release l-arginine formulations and methods of manufacture and use |